ALLOVIR INC (ALVR) Fundamental Analysis & Valuation
NASDAQ:ALVR • US0198181036
Current stock price
9.81 USD
+0.15 (+1.55%)
Last:
This ALVR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ALVR Profitability Analysis
1.1 Basic Checks
- ALVR had negative earnings in the past year.
- In the past year ALVR has reported a negative cash flow from operations.
- In the past 5 years ALVR always reported negative net income.
- In the past 5 years ALVR always reported negative operating cash flow.
1.2 Ratios
- ALVR has a Return On Assets (-49.57%) which is in line with its industry peers.
- The Return On Equity of ALVR (-51.87%) is better than 63.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -49.57% | ||
| ROE | -51.87% | ||
| ROIC | N/A |
ROA(3y)-73.56%
ROA(5y)-51.32%
ROE(3y)-94.03%
ROE(5y)-64.29%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for ALVR so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. ALVR Health Analysis
2.1 Basic Checks
- The number of shares outstanding for ALVR has been reduced compared to 1 year ago.
- ALVR has less shares outstanding than it did 5 years ago.
- There is no outstanding debt for ALVR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- Based on the Altman-Z score of -3.17, we must say that ALVR is in the distress zone and has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of -3.17, ALVR is in line with its industry, outperforming 47.89% of the companies in the same industry.
- ALVR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -3.17 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- ALVR has a Current Ratio of 22.63. This indicates that ALVR is financially healthy and has no problem in meeting its short term obligations.
- With an excellent Current ratio value of 22.63, ALVR belongs to the best of the industry, outperforming 96.49% of the companies in the same industry.
- A Quick Ratio of 22.63 indicates that ALVR has no problem at all paying its short term obligations.
- Looking at the Quick ratio, with a value of 22.63, ALVR belongs to the top of the industry, outperforming 96.49% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 22.63 | ||
| Quick Ratio | 22.63 |
3. ALVR Growth Analysis
3.1 Past
- ALVR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.78%, which is quite impressive.
EPS 1Y (TTM)25.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-595.49%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- Based on estimates for the next years, ALVR will show a very strong growth in Earnings Per Share. The EPS will grow by 20.08% on average per year.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y69.66%
EPS Next 2Y35.01%
EPS Next 3Y20.08%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. ALVR Valuation Analysis
4.1 Price/Earnings Ratio
- ALVR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALVR. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as ALVR's earnings are expected to grow with 20.08% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.01%
EPS Next 3Y20.08%
5. ALVR Dividend Analysis
5.1 Amount
- No dividends for ALVR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ALVR Fundamentals: All Metrics, Ratios and Statistics
NASDAQ:ALVR (3/18/2025, 8:21:54 PM)
9.81
+0.15 (+1.55%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-13 2025-03-13/amc
Earnings (Next)05-12 2025-05-12
Inst Owners42.88%
Inst Owner Change-94.24%
Ins Owners6.37%
Ins Owner Change0%
Market Cap49.44M
Revenue(TTM)N/A
Net Income(TTM)-58.77M
Analysts43.33
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | N/A | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.44 | ||
| P/tB | 0.44 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.67
EYN/A
EPS(NY)-0.3
Fwd EYN/A
FCF(TTM)-24.69
FCFYN/A
OCF(TTM)-24.69
OCFYN/A
SpS0
BVpS22.48
TBVpS22.48
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -49.57% | ||
| ROE | -51.87% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-73.56%
ROA(5y)-51.32%
ROE(3y)-94.03%
ROE(5y)-64.29%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 22.63 | ||
| Quick Ratio | 22.63 | ||
| Altman-Z | -3.17 |
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-595.49%
EPS Next Y69.66%
EPS Next 2Y35.01%
EPS Next 3Y20.08%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y69.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year63.06%
EBIT Next 3Y18.66%
EBIT Next 5YN/A
FCF growth 1Y12.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.39%
OCF growth 3YN/A
OCF growth 5YN/A
ALLOVIR INC / ALVR Fundamental Analysis FAQ
What is the fundamental rating for ALVR stock?
ChartMill assigns a fundamental rating of 3 / 10 to ALVR.
What is the valuation status of ALLOVIR INC (ALVR) stock?
ChartMill assigns a valuation rating of 1 / 10 to ALLOVIR INC (ALVR). This can be considered as Overvalued.
What is the profitability of ALVR stock?
ALLOVIR INC (ALVR) has a profitability rating of 1 / 10.
Can you provide the expected EPS growth for ALVR stock?
The Earnings per Share (EPS) of ALLOVIR INC (ALVR) is expected to grow by 69.66% in the next year.